Fig. 2From: Repeat stereotactic body radiotherapy (SBRT) for local recurrence of non-small cell lung cancer and lung metastasis after first SBRTOverall survival (OS), progression-free survival (PFS), and local control (LC) rates after second SBRT in 23 NSCLC patientsBack to article page